Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN UZBEKISTAN
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Growth in Number of Allergy Sufferers
Cough Remedies Are Mostly Consumed in Winter, Especially Among Children
New Launches Set To Boost Cough, Cold and Allergy (hay Fever) Remedies
Competitive Landscape
Multinationals, Led by Nycomed, Characterise Category Sales
Fervex by Bristol-Myers Outperforms Gsk's Coldrex Largely Due To Its Lower Cost
Uzbekistani Producers Remain Weak
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Executive Summary
Prospects Are Promising for the Uzbekistani Consumer Health Market
New Regulations Influence the Market in 2018
Growth in the Number of Domestic Producers
Regulations Limit Sale of Consumer Health Products To Chemists/pharmacies
Modest Value Growth Predicted for Consumer Health
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
According to the Chief Allergist of the Ministry of Health of the Republic of Uzbekistan, even 15 years ago only 5-10% of the population suffered from allergies. Today, due to the impact of a variety of factors, this percentage has increased significantly. Allergies are most prolific or exacerbated during spring in Uzbekistan. Therefore, the main sales of antihistamines/allergy remedies (systemic) increase in April and May. Usually, people ask pharmacists to recommend products with brands, such...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.